Clinical Trials Browser

Phase 2 × Neurocognitive × osimertinib × Clear all

NCT04829019 2021-04-02

Neurocognition in NSCLC Patients Treated With Osimertinib or Osimertinib + WBI

Phase 2 Unknown

Neurocognitive